Global eClinical Solutions Market to 2025: Market to Reach $12.05 Bn - Rising Application of Software Solutions in Clinical Trials
DUBLIN, Sept. 6, 2018 /PRNewswire/ --
The "eClinical Solutions Market Size, Share, & Trends Analysis Report By Product (CTMS, eCOA, EDC & CDMS), By Delivery Mode (Web-hosted, Cloud-based), By Development Phase, By End Use, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.
The global eClinical solutions market size is expected to reach USD 12.05 million by 2025, progressing at a CAGR of 13.6% during the forecast period.
Increasing research and development activities by biopharma and pharma companies, rising application of software solutions in clinical trials, and expanding customer base are anticipated to fuel the demand for eClinical solutions.
The eClinical solutions market is estimated to witness phenomenal growth over the forecast period. Technological advancements in the field of clinical trials such as electronic data capture and prevalence of Wi-Fi connectivity are projected to drive the market in coming years. As the demand for tracking and analyzing clinical data increases, the need for effective clinical solutions rises. Unmet needs to manage efficient clinical development process are poised to boost the growth of the market over the forecast period.
Moreover, digital transformation in the field of clinical trials and shifting preference towards data centric approach are providing a tremendous push to the market. Demand for integrated clinical IT solutions is increasing due to massive volume of data generated during clinical development processes. eClinical solutions offer single source of information that helps in optimizing the cost by eliminating redundant data entry and reducing on-site verification and source data verification rate. Rising awareness regarding these benefits is propelling the market.
Adoption of eClinical workflows in trials offer enormous potential in clinical development processes. These solutions can facilitate decision making in each stage of development. It also helps in reducing cost & time between development phase by utilizing seamless designs & identifying failing compounds. In addition, it offers rapid access to data & patient safety information, which is helpful in making quick decisions.
Further Key Findings From the Study Suggest:
- CTMS dominated the product segment in 2016 owing to associated benefits such as centralized end-to-end management of clinical trial activities, elimination of reliance on manual processes, real-time status tracking, and maintenance of multiple databases, which cumulatively improve the overall efficiency of clinical trials
- On-premise eClinical solutions are most commonly preferred solutions. The preference for these services is mainly due to complete access to information and have full control within the premise
- Key market players are engaged in various strategies such as mergers & acquisitions and new product development to gain market penetration
- New product development and strategic alliances including partnership agreements, promotional activities, and acquisitions are instrumental in keeping market rivalry high
- For instance, in February 2016, Oracle Health Sciences entered into an agreement with Bayer Healthcare to provide its clinical e-monitoring solutions, Oracle Siebel Clinical Trial Management System, to the latter
Key Topics Covered:
Chapter 1 Report Scope
1.1 Segment Market Scope
1.2 Regional Scope
1.3 Estimates & Forecast Timeline
Chapter 2 Research Methodology
2.1 Model Details
2.2 Information Procurement
2.3 List of Primary Sources
2.4 Purchased database
2.5 Internal database
2.6 Primary interview breakup
Chapter 3 Report Objectives
3.1 Objectives
Chapter 4 Executive Summary
4.1 Market Summary
Chapter 5 Market Definitions
Chapter 6 Industry Outlook
6.1 Business Segment Trend Analysis
6.2 Pricing Analysis
6.2.1 By Product
6.2.1.1 eCOA
6.2.1.2 EDC & CDMS
6.2.1.3 Clinical Analytics Platforms
6.2.1.4 Clinical data integration platforms
6.2.1.5 Safety solutions
6.2.1.6 CTMS
6.2.1.7 RTSM
6.2.1.8 eTMF
6.2.2 BY Delivery mode
6.2.3 by Development phase
6.2.4 by End-use
6.3 Market Variable Analysis
6.3.1 Market Driver Analysis
6.3.1.1 Increasing externalization of clinical trial studies by large pharmaceutical and biopharmaceutical companies
6.3.1.2 Advantages of eClinical solutions
6.3.1.3 Presence of strong range of products in pipeline
6.3.2 Market Restraints Analysis
6.3.2.1 Scarcity of skilled research professionals
6.3.2.2 Lack of recognition
6.4 Business Environment Analysis Tools
6.4.1 eClinical solutions: Market dynamics
6.4.2 eClinical solutions - SWOT analysis, by factor (political & legal, economic and technological)
6.4.3 Penetration & growth prospect mapping by delivery mode, 2016
Chapter 7 Regulatory & Political Forces
7.1 Regulatory Landscape
7.1.1 List of regulations, by country
7.2 Political Landscape, Current & Future Scenario
Chapter 8 Competitive & Vendor Landscape
8.1 Market Participation Categorization
8.1.1 Market leader
8.1.2 Innovators
8.2 Strategic Initiatives & Outcome Analysis
8.2.1 List of key strategies, by company
8.3 List of Key Companies, By Region
8.3.1 North America
8.3.2 Europe
8.3.3 Asia Pacific
8.3.4 Central & South America
8.3.5 MEA
8.4 Company Market Share Analysis
8.4.1 eClinical solutions company market share analysis, 2016
8.5 Vendor Landscape
8.5.1 List of eClinical service providers
Chapter 9 eClinical Solutions Market: Product Analysis
9.1 Product Business Analysis
9.1.1 Electronic clinical outcome assessment (ECOA)
9.1.2 Electronic data capture (EDC) & clinical data management systems (CDMS)
9.1.3 Clinical analytics platform
9.1.4 Clinical data integration platform
9.1.5 Safety solutions
9.1.6 Clinical trial management systems (CTMS)
9.1.7 Randomization and trial supply management (RTSM)
9.1.8 Electronic trial master file (eTMF)
Chapter 10 eClinical Solutions Market: Delivery Mode Analysis
10.1 Delivery Mode Business Analysis
10.1.1 Web-hosted
10.1.2 Licensed Enterprise
10.1.3 Cloud-based
Chapter 11 eClinical Solutions Market: Development Phase Analysis
11.1 Development Phase Business Analysis
11.1.1 Phase I
11.1.2 Phase II
11.1.3 Phase III
11.1.4 Phase IV
Chapter 12 eClinical Solutions Market: End-use Analysis
12.1 End-use Business Analysis
12.1.1 Hospitals
12.1.2 Contract Research Organizations (CROs)
12.1.3 Academic institutes
12.1.4 Pharma & biotech organizations
12.1.5 Medical device manufacturers
Chapter 13 Market Variables, Trends & Scope
Chapter 14 Company Profiles
- Oracle
- PAREXEL International Corporation
- Medidata Solution, Inc.
- Bioclinica
- DATATRAK International, Inc.
- CRF Health
- ERT Clinical
- eClinicalWorks
- IBM Watson Health
- OmniComm Systems, Inc.
- eClinical Solutions
For more information about this report visit
https://www.researchandmarkets.com/research/nblxt3/global_eclinical?w=5
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.
Media Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article